Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children

Area of Science:

• Pediatric infectious diseases
• Immunology
• Virology

Background:

• Multisystem inflammatory syndrome in children (MIS-C) is a rare, severe condition linked to COVID-19.
• MIS-C presents with diverse systemic inflammation symptoms affecting multiple organs.
• A global trend of reduced MIS-C incidence and severity has been observed.

Purpose of the Study:

• To review the literature on the declining trend of MIS-C.
• To hypothesize factors contributing to the reduction in MIS-C incidence and severity.
• To explore the roles of vaccination, SARS-CoV-2 variants, and immune response changes.

Main Methods:

• Literature review focusing on global MIS-C trends.
• Analysis of potential influencing factors: vaccination, viral variants, and immunological changes.
• Hypothesis generation based on observed epidemiological shifts.

Main Results:

• A progressive reduction in MIS-C incidence and severity is evident worldwide.
• Multiple factors, not a single cause, appear responsible for the decline.
• Vaccination, SARS-CoV-2 variant mutations (S protein), and acquired immunity contribute significantly.

Conclusions:

• The decrease in MIS-C is multifactorial, involving vaccination and viral evolution.
• Maturing immunological memory and variant-specific immune responses play key roles.
• Understanding these factors is crucial for managing pediatric inflammatory syndromes post-COVID-19.